First Time Loading...

Beijing Hotgen Biotech Co Ltd
SSE:688068

Watchlist Manager
Beijing Hotgen Biotech Co Ltd Logo
Beijing Hotgen Biotech Co Ltd
SSE:688068
Watchlist
Price: 30.22 CNY 0.43% Market Closed
Updated: Mar 28, 2024

Intrinsic Value

Beijing Hotgen Biotech Co., Ltd. engages in the development and manufacturing of in-vitro diagnostic, point-of-care-testing, and biodefense products. [ Read More ]

The intrinsic value of one Beijing Hotgen Biotech Co Ltd stock under the Base Case scenario is 170.29 CNY. Compared to the current market price of 30.22 CNY, Beijing Hotgen Biotech Co Ltd is Undervalued by 82%.

Key Points:
Intrinsic Value
Base Case
170.29 CNY
Undervaluation 82%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Beijing Hotgen Biotech Co Ltd

Backtest Beijing Hotgen Biotech Co Ltd Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Beijing Hotgen Biotech Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Beijing Hotgen Biotech Co Ltd's business.

What risks and challenges
does Beijing Hotgen Biotech Co Ltd face in the near future?

Summarize the latest earnings report
of Beijing Hotgen Biotech Co Ltd.

Provide P/E
for Beijing Hotgen Biotech Co Ltd and its competitors.

Financials

Balance Sheet Decomposition
Beijing Hotgen Biotech Co Ltd

Current Assets 931.3m
Cash & Short-Term Investments 468.4m
Receivables 121.6m
Other Current Assets 341.2m
Non-Current Assets 2.7B
Long-Term Investments 1.3B
PP&E 1.1B
Intangibles 54.2m
Other Non-Current Assets 158.2m
Current Liabilities 169.1m
Accounts Payable 113m
Accrued Liabilities 21.6m
Other Current Liabilities 34.5m
Non-Current Liabilities 34.1m
Long-Term Debt 12.6m
Other Non-Current Liabilities 21.5m
Efficiency

Earnings Waterfall
Beijing Hotgen Biotech Co Ltd

Revenue
954.3m CNY
Cost of Revenue
-471.6m CNY
Gross Profit
482.7m CNY
Operating Expenses
-650.4m CNY
Operating Income
-167.7m CNY
Other Expenses
65.3m CNY
Net Income
-102.4m CNY

Free Cash Flow Analysis
Beijing Hotgen Biotech Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Beijing Hotgen Biotech Co Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Exceptional 3-Years Revenue Growth
Positive Gross Profit
69/100
Profitability
Score

Beijing Hotgen Biotech Co Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Beijing Hotgen Biotech Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Beijing Hotgen Biotech Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Beijing Hotgen Biotech Co Ltd

There are no price targets for Beijing Hotgen Biotech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Beijing Hotgen Biotech Co Ltd

1M 1M
-6%
6M 6M
-23%
1Y 1Y
-39%
3Y 3Y
+8%
5Y 5Y
-32%
10Y 10Y
-32%
Annual Price Range
30.22
52w Low
24.56
52w High
53.15
Price Metrics
Average Annual Return 29.91%
Standard Deviation of Annual Returns 101.98%
Max Drawdown -84%
Shares Statistics
Market Capitalization 2.8B CNY
Shares Outstanding 92 268 766
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Beijing Hotgen Biotech Co Ltd Logo
Beijing Hotgen Biotech Co Ltd

Country

China

Industry

Life Sciences Tools & Services

Market Cap

2.8B CNY

Dividend Yield

0%

Description

Beijing Hotgen Biotech Co., Ltd. engages in the development and manufacturing of in-vitro diagnostic, point-of-care-testing, and biodefense products. The company is headquartered in Beijing, Beijing and currently employs 1,019 full-time employees. The company went IPO on 2019-09-30. The firm's products mainly include in vitro diagnostic reagents, in vitro diagnostic instruments and biological raw materials. Its products are mainly used in clinical fields such as liver cancer, hepatitis, cardiovascular and cerebrovascular diseases, and inflammatory infections, as well as in public safety and other fields such as biosafety, food safety, and disease control and emergency response. The firm primarily conducts its businesses in domestic and overseas markets.

Contact

BEIJING
Beijing
Block 10, Zhongguancun High-end Medical Device Industrial Park, No. 26 Yongwang West Road, Daxing District
+861050973660
http://www.hotgen.com.cn/

IPO

2019-09-30

Employees

1 019

Officers

Chairman & GM
Mr. Changqing Lin

See Also

Discover More
What is the Intrinsic Value of one Beijing Hotgen Biotech Co Ltd stock?

The intrinsic value of one Beijing Hotgen Biotech Co Ltd stock under the Base Case scenario is 170.29 CNY.

Is Beijing Hotgen Biotech Co Ltd stock undervalued or overvalued?

Compared to the current market price of 30.22 CNY, Beijing Hotgen Biotech Co Ltd is Undervalued by 82%.